NCT00299091View on ClinicalTrials.gov

Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
HIV
Interventions
DRUG

Efavirenz capsules 200 mg and 600 mg

Modification of doses of efavirenz guided by its plasma concentration (therapeutic drug monitoring)

Trial Locations (1)

08916

Germans Trias i Pujol Hospital, Badalona

All Listed Sponsors
lead

Germans Trias i Pujol Hospital

OTHER

NCT00299091 - Modification of Doses of Efavirenz According to Its Blood Concentration in HIV Patients | Biotech Hunter | Biotech Hunter